Bajaten en es it fr

Bajaten Brand names, Bajaten Analogs

Bajaten Brand Names Mixture

  • No information avaliable

Bajaten Chemical_Formula


Bajaten RX_link

Bajaten fda sheet

Bajaten FDA

Bajaten msds (material safety sheet)

Bajaten MSDS

Bajaten Synthesis Reference

No information avaliable

Bajaten Molecular Weight

365.835 g/mol

Bajaten Melting Point

161 oC

Bajaten H2O Solubility

75 mg/L

Bajaten State


Bajaten LogP


Bajaten Dosage Forms


Bajaten Indication

For the treatment of hypertension, alone or in combination with other antihypertensive drugs as well as for the treatment of salt and fluid retention associated with congestive heart failure or edema from pregnancy.

Bajaten Pharmacology

Indapamide is an antihypertensive and a diuretic. It contains both a polar sulfamoyl chlorobenzamide moiety and a lipid- soluble methylindoline moiety. Indapamide bears a structural similarity to the triazide diuretics which are known to decrease vascular smooth muscle reactivity. However, it differs chemically from the thiazides in that it does not possess the thiazide ring system and contains only one sulfonamide group. Indapamide appears to cause vasodilation, probably by inhibiting the passage of calcium and other ions (sodium, potassium) across membranes. This same effect may cause hypokalcemia in susceptible individuals. Indapamide has also been shown to cause uterine myometrial relaxation in experimental animals. Overall, indapamide has an extra-renal antihypertensive action resulting in a decrease in vascular hyperreactivity and a reduction in total peripheral and arteriolar resistance.

Bajaten Absorption

Rapidly absorbed from gastrointestinal tract.

Bajaten side effects and Toxicity

Side effects include electrolyte imbalance (potassium or salt depletion due to too much fluid loss), nausea, stomach disorders, vomiting, weakness

Bajaten Patient Information

No information avaliable

Bajaten Organisms Affected

Humans and other mammals